Cas:219726-62-2 but-1-enylcyclopentane manufacturer & supplier

We serve Chemical Name:but-1-enylcyclopentane CAS:219726-62-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

but-1-enylcyclopentane

Chemical Name:but-1-enylcyclopentane
CAS.NO:219726-62-2
Synonyms:Cyclopentane,1-buten-1-yl;1-Butenylcyclopentane;Cyclopentane,2-butenyl;trans-1-Butenylcyclopentane
Molecular Formula:C9H16
Molecular Weight:124.22300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:124.12500
LogP:3.14280

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Cyclopentane,1-buten-1-yl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-1-Butenylcyclopentane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclopentane,1-buten-1-yl Use and application,Cyclopentane,2-butenyl technical grade,usp/ep/jp grade.


Related News: Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. but-1-enylcyclopentane manufacturer Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. but-1-enylcyclopentane supplier Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. but-1-enylcyclopentane vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. but-1-enylcyclopentane factory I believe they came to the right decision on behalf of the American public, Sandrock said in an interview.